Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Bushen Huoxue for the Treatment of Premature Ovarian Insufficiency
Bushen Huoxue (BSHX) has been applied in clinical traditional Chinese medicine treatment, and has definitive clinical efficacy in the treatment of Premature Ovarian Insufficiency (POI) in China. However, little is known of the underlying mechanism of BSHX. The purpose of this paper is to study the p...
Guardado en:
Autores principales: | Ying Cao, Yue Chen, Peijuan Wang, Jialin Lu, Xuan Han, Jingyao She |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72961efa2e264f698608279df808953b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effectiveness and safety of Bushen Huoxue granules in treatment of premature ovarian insufficiency: study protocol for a randomized, double-blinded, placebo-controlled, and multicenter clinical trial
por: Ying Cao, et al.
Publicado: (2021) -
Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure
por: Jiying Chen, et al.
Publicado: (2021) -
Bushen Huoxue Acupuncture Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in SAMP8 Mouse Model of Alzheimer’s Disease
por: Zhang T, et al.
Publicado: (2021) -
Modern Concepts of Clinical and Diagnostic Criteria for Premature Ovarian Failure (Literature Review)
por: M. D. Salimova, et al.
Publicado: (2021) -
Study on the mechanism of Guizhi Fuling pill in the treatment of ovarian cancer based on network pharmacology and molecular docking
por: Xiao-Qing Wu, et al.
Publicado: (2021)